Analyst Articles – US

Zacks Investment Research Upgrades Blue Capital Reinsurance Holdings Ltd. (BCRH) to “Hold”

Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a report released on Wednesday. According to Zacks, “Blue Capital Holdings Ltd. is a reinsurance holding company. It offers collateralized reinsurance in the property catastrophe market. Blue Capital Holdings Ltd. is based in […]

CoLucid Pharmaceuticals, Inc. (CLCD) Cut to Market Perform at William Blair

CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD) was downgraded by stock analysts at William Blair from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Wednesday. A number of other analysts have also issued reports on CLCD. Piper Jaffray Companies lowered CoLucid Pharmaceuticals from an “overweight” rating to a […]

Hologic, Inc. (HOLX) Downgraded to Hold at Zacks Investment Research

Zacks Investment Research downgraded shares of Hologic, Inc. (NASDAQ:HOLX) from a buy rating to a hold rating in a report issued on Tuesday. According to Zacks, “Over the past six months, Hologic has consistently traded higher than the Zacks categorized broader Medical products industry. A series of consistent product launches along with strong focus on […]

Honda Motor Company, Ltd. (HMC) Upgraded to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of Honda Motor Company, Ltd. (NYSE:HMC) from a hold rating to a buy rating in a research note released on Tuesday. They currently have $34.00 target price on the stock. According to Zacks, “Honda’s shares have underperformed the Zacks categorized Foreign Auto Manufacturers industry over the last 3 months. The […]

ImmunoGen, Inc. (IMGN) Downgraded by Zacks Investment Research to “Sell”

Zacks Investment Research lowered shares of ImmunoGen, Inc. (NASDAQ:IMGN) from a hold rating to a sell rating in a research report released on Tuesday morning. According to Zacks, “ImmunoGen is a development-stage biotechnology company focused on the development of targeted anti-cancer therapeutics using ADC technology. It has only a limited number of wholly owned candidates […]

Cellular Biomedicine Group, Inc. (CBMG) Given a $18.00 Price Target at Maxim Group

Maxim Group set a $18.00 price target on Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) in a research report sent to investors on Tuesday morning. The brokerage currently has a buy rating on the stock. Cellular Biomedicine Group (NASDAQ:CBMG) traded down 1.16% during trading on Tuesday, hitting $12.80. The stock had a trading volume of 4,570 shares. […]

CyberArk Software Ltd. (CYBR) Downgraded to Sell at Zacks Investment Research

Zacks Investment Research cut shares of CyberArk Software Ltd. (NASDAQ:CYBR) from a hold rating to a sell rating in a research note released on Tuesday. According to Zacks, “Israel-based Cybersecurity firm, CyberArk's near-term prospects are not promising as changing customer spending behavior has recently hit several other players in this space. Intensifying competition from peers […]

Epizyme, Inc. (EPZM) Downgraded by Zacks Investment Research to “Hold”

Zacks Investment Research downgraded shares of Epizyme, Inc. (NASDAQ:EPZM) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning. According to Zacks, “Epizyme’s efforts on developing its lead candidate, tazemetostat, for a number of hematological malignancies and genetically defined solid tumors are impressive. Moreover, the company’s efforts […]

Electronic Arts Inc. (EA) Lowered to “Hold” at Zacks Investment Research

Zacks Investment Research lowered shares of Electronic Arts Inc. (NASDAQ:EA) from a buy rating to a hold rating in a research report sent to investors on Tuesday. According to Zacks, “Electronic Arts’ digital business is expected to continue to grow in fiscal 2017 and beyond, primarily on the back of a strong mobile business. Moreover, […]

Expeditors International of Washington, Inc. (EXPD) Upgraded by Zacks Investment Research to “Hold”

Zacks Investment Research upgraded shares of Expeditors International of Washington, Inc. (NASDAQ:EXPD) from a sell rating to a hold rating in a research note released on Tuesday morning. According to Zacks, “Shares of Expeditors have outperformed the broader  industry over the last three months. We are encouraged by Expeditors' efforts to reward shareholders through dividend […]

BT Group PLC (BT) Downgraded by Zacks Investment Research to “Sell”

Zacks Investment Research cut shares of BT Group PLC (NYSE:BT) from a hold rating to a sell rating in a research note issued to investors on Tuesday morning. According to Zacks, “BT is one of the world’s leading providers of communications services and solutions, serving customers in more than 170 countries. Its principal activities include […]

CNB Financial Corporation (CCNE) Upgraded to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of CNB Financial Corporation (NASDAQ:CCNE) from a strong sell rating to a hold rating in a research note published on Tuesday. According to Zacks, “CNB Financial Corporation is a bank holding company headquartered in Clearfield, PA. It conducts business principally through County National Bank whose market area includes twenty convenient […]

Aercap Holdings N.V. (AER) Downgraded to Sell at Zacks Investment Research

Zacks Investment Research cut shares of Aercap Holdings N.V. (NYSE:AER) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning. According to Zacks, “AERCAP HOLDINGS is an integrated global aviation company with a leading market position in aircraft and engine leasing, trading and parts sales.They also provides […]

Angie’s List, Inc. (ANGI) Upgraded by Zacks Investment Research to “Hold”

Zacks Investment Research upgraded shares of Angie’s List, Inc. (NASDAQ:ANGI) from a strong sell rating to a hold rating in a research report released on Tuesday morning. According to Zacks, “Angie’s List Inc. provides information, reports and reviews about service companies. The Company offers product and company reviews, actively collects data on listed companies, and […]

Aegean Marine Petroleum Network Inc. (ANW) Downgraded to “Sell” at Zacks Investment Research

Zacks Investment Research cut shares of Aegean Marine Petroleum Network Inc. (NYSE:ANW) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning. According to Zacks, “AEGEAN MARINE PETROLEUM is a marine fuel logistics company that physically supplies and markets refined marine fuel and lubricants to ships in […]

Aggreko PLC (ARGKF) Upgraded to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of Aggreko PLC (NASDAQ:ARGKF) from a sell rating to a buy rating in a research note issued to investors on Tuesday morning. Zacks Investment Research currently has $13.00 target price on the stock. According to Zacks, “Aggreko plc provides rental solutions to energy sector primarily of power generation and temperature […]

Asure Software Inc (ASUR) Lowered to “Sell” at Zacks Investment Research

Zacks Investment Research lowered shares of Asure Software Inc (NASDAQ:ASUR) from a hold rating to a sell rating in a research note published on Tuesday morning. According to Zacks, “Asure Software Inc., formerly Forgent Networks, Inc., is a provider of Web-based workforce management solutions. It offers Web-based workforce management solutions that enable organizations to manage […]

Argus Reaffirms “Hold” Rating for Humana Inc. (HUM)

Humana Inc. (NYSE:HUM)‘s stock had its “hold” rating restated by investment analysts at Argus in a report issued on Wednesday. Several other research firms have also commented on HUM. Jefferies Group reaffirmed a “buy” rating and set a $230.00 target price (up from $206.00) on shares of Humana in a report on Thursday, December 1st. […]

Aimmune Therapeutics, Inc. (AIMT) Downgraded by Zacks Investment Research to Hold

Zacks Investment Research lowered shares of Aimmune Therapeutics, Inc. (NASDAQ:AIMT) from a buy rating to a hold rating in a research note released on Tuesday morning. According to Zacks, “Aimmune Therapeutics, Inc. is a biopharmaceutical company which is engaged in the development of desensitization treatments for peanut and other food allergies. The Company’s characterized oral […]

Hilton Worldwide Holdings Inc. (HLT) Price Target Raised to $62.00 at Royal Bank Of Canada

Hilton Worldwide Holdings Inc. (NYSE:HLT) had its price objective raised by Royal Bank Of Canada from $26.00 to $62.00 in a research note issued to investors on Tuesday morning. They currently have an outperform rating on the stock. Several other equities research analysts also recently weighed in on HLT. TheStreet downgraded shares of Hilton Worldwide […]

First Republic Bank (FRC) Given New $105.00 Price Target at FBR & Co

First Republic Bank (NYSE:FRC) had its price objective increased by FBR & Co from $100.00 to $105.00 in a report published on Tuesday morning. They currently have an outperform rating on the stock. A number of other equities analysts have also weighed in on FRC. Zacks Investment Research lowered First Republic Bank from a buy […]

Cambrex Corporation (CBM) Price Target Increased to $66.00 by Analysts at First Analysis

Cambrex Corporation (NYSE:CBM) had its price objective raised by First Analysis from $54.00 to $66.00 in a research note issued to investors on Tuesday morning. They currently have an overweight rating on the stock. Separately, Zacks Investment Research raised shares of Cambrex Corporation from a hold rating to a strong-buy rating and set a $53.00 […]

Dicerna Pharmaceuticals, Inc. (DRNA) Downgraded by Zacks Investment Research to Hold

Zacks Investment Research lowered shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) from a strong-buy rating to a hold rating in a report released on Tuesday morning. According to Zacks, “Dicerna Pharmaceuticals, Inc. is focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers. The company uses its […]

Chipotle Mexican Grill, Inc. (CMG) Downgraded to Neutral at J P Morgan Chase & Co

J P Morgan Chase & Co lowered shares of Chipotle Mexican Grill, Inc. (NYSE:CMG) from an overweight rating to a neutral rating in a report published on Tuesday. J P Morgan Chase & Co currently has $375.00 price objective on the stock. CMG has been the subject of several other reports. RBC Capital Markets reaffirmed […]

Danone SA (DANOY) Upgraded to “Hold” by Zacks Investment Research

Zacks Investment Research upgraded shares of Danone SA (NASDAQ:DANOY) from a sell rating to a hold rating in a research note released on Tuesday. According to Zacks, “Danone SA is engaged in food processing activities primarily in France and internationally. The Company operates in four business lines: Fresh Dairy Products, Waters, Baby Nutrition, and Medical […]

Carbo Ceramics, Inc. (CRR) Upgraded by Zacks Investment Research to “Buy”

Zacks Investment Research upgraded shares of Carbo Ceramics, Inc. (NYSE:CRR) from a hold rating to a buy rating in a research note published on Tuesday morning. They currently have $12.00 price target on the stock. According to Zacks, “CARBO Ceramics Inc. is the world’s largest producer and supplier of ceramic proppants for use in the […]

Cameco Corporation (CCJ) Upgraded to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of Cameco Corporation (NYSE:CCJ) (TSE:CCO) from a hold rating to a buy rating in a research report released on Tuesday. The brokerage currently has $15.00 price objective on the stock. According to Zacks, “Cameco Corporation is the world’s largest publicly traded uranium company and a growing gold producer. Its uranium […]

WPX Energy, Inc. (WPX) Given “Outperform” Rating at FBR & Co

FBR & Co reiterated their outperform rating on shares of WPX Energy, Inc. (NYSE:WPX) in a research report report published on Tuesday morning. The brokerage currently has a $19.00 price objective on the stock. Several other equities research analysts have also recently issued reports on the stock. BMO Capital Markets reaffirmed a buy rating and […]

Unum Group (UNM) Upgraded to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Unum Group (NYSE:UNM) from a hold rating to a buy rating in a research report report published on Tuesday. Zacks Investment Research currently has $50.00 price objective on the stock. According to Zacks, “Shares of Unum Group significantly outperformed the Zacks categorized Accident & Health industry, over the last […]

Target Corporation (TGT) Downgraded by Zacks Investment Research to “Hold”

Zacks Investment Research lowered shares of Target Corporation (NYSE:TGT) from a buy rating to a hold rating in a research note published on Tuesday. According to Zacks, “Target, whose estimates have been stable lately ahead of fourth-quarter earnings release, has outpaced the sector in the past three months. We believe that the initiatives such as […]

Regal Beloit Corporation (RBC) Lowered to Sell at Zacks Investment Research

Zacks Investment Research downgraded shares of Regal Beloit Corporation (NYSE:RBC) from a hold rating to a sell rating in a report published on Tuesday morning. According to Zacks, “Regal Beloit’s business strategy hinges on acquiring companies and making investments that complement its existing businesses. These acquisitions consume significant resources, which could adversely affect its operating […]

Pfizer, Inc. (PFE) Downgraded by Zacks Investment Research to “Hold”

Zacks Investment Research cut shares of Pfizer, Inc. (NYSE:PFE) from a buy rating to a hold rating in a report published on Tuesday. According to Zacks, “Pfizer has been working on strengthening its product portfolio as well as pipeline through acquisitions and licensing deals. While the Hospira acquisition significantly expanded Pfizer's sterile injectable and biosimilar […]

Prosperity Bancshares, Inc. (PB) Upgraded to Buy by Zacks Investment Research

Zacks Investment Research upgraded shares of Prosperity Bancshares, Inc. (NYSE:PB) from a hold rating to a buy rating in a research report report published on Tuesday morning. They currently have $81.00 price objective on the stock. According to Zacks, “Prosperity Bancshares shares outperformed the Zacks categorized Banks-Southwest industry over the last six months. Quarterly estimates […]

Tianyin Pharmaceutical Inc Co (TPI) Now Covered by Analysts at Roth Capital

Roth Capital assumed coverage on shares of Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI) in a research report report published on Tuesday morning. The brokerage issued a buy rating and a $23.00 price objective on the stock. Tianyin Pharmaceutical (NYSEMKT:TPI) remained flat at $0.16 on Tuesday. Tianyin Pharmaceutical has a 12 month low of $0.10 and a […]

EASYJET SPON ADR EA REP 4 (ESYJY) Upgraded by Kepler Capital Markets to Hold

Kepler Capital Markets upgraded shares of EASYJET SPON ADR EA REP 4 (OTC:ESYJY) from a reduce rating to a hold rating in a research note issued to investors on Tuesday, StockTargetPrices.com reports. Separately, Royal Bank Of Canada downgraded EASYJET SPON ADR EA REP 4 from a sector perform rating to an underperform rating in a […]

Antofagasta plc (ANFGY) Upgraded to “Hold” by HSBC

HSBC upgraded shares of Antofagasta plc (OTCMKTS:ANFGY) from a reduce rating to a hold rating in a research note published on Tuesday morning. A number of other equities research analysts have also commented on ANFGY. Deutsche Bank AG reiterated a hold rating on shares of Antofagasta plc in a research report on Wednesday, December 7th. […]

AMC Entertainment Holdings, Inc. (AMC) Earns Buy Rating from MKM Partners

AMC Entertainment Holdings, Inc. (NYSE:AMC)‘s stock had its “buy” rating reaffirmed by stock analysts at MKM Partners in a note issued to investors on Wednesday. They currently have a $45.00 price objective on the stock. MKM Partners’ target price suggests a potential upside of 32.74% from the company’s previous close. A number of other equities […]

Imax Corporation (IMAX) Receives “Buy” Rating from MKM Partners

Imax Corporation (NYSE:IMAX)‘s stock had its “buy” rating reissued by equities researchers at MKM Partners in a report released on Wednesday. They currently have a $40.00 price objective on the stock. MKM Partners’ price target would suggest a potential upside of 26.18% from the company’s previous close. Several other equities analysts have also commented on […]

Engility Holdings, Inc. (EGL) Downgraded by Zacks Investment Research to Hold

Zacks Investment Research cut shares of Engility Holdings, Inc. (NYSE:EGL) from a strong-buy rating to a hold rating in a research note published on Tuesday. According to Zacks, “Engility Holdings, Inc. is engaged in providing government services in engineering, professional support and mission support to customers in the U.S. Department of Defense, Federal civilian agencies […]

Nordstrom, Inc. (JWN) Downgraded to “Hold” at Stifel Nicolaus

Stifel Nicolaus downgraded shares of Nordstrom, Inc. (NYSE:JWN) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning. They currently have $40.00 target price on the stock, down from their prior target price of $62.00. JWN has been the topic of several other reports. Credit Suisse Group […]